-+ 0.00%
-+ 0.00%
-+ 0.00%

Union Korea Pharm Cancels 243,338 Common Shares

PUBT·11/18/2026 00:48:02
Listen to the news
Union Korea Pharm Cancels 243,338 Common Shares
  • Union Korea Pharm completed a capital reduction canceling 243,338 common shares on Nov. 13, 2026.
  • Total common shares outstanding fell to 79,972,918 from 80,216,256.
  • Share capital declined to KRW 39.99 billion from KRW 40.11 billion.
  • The canceled shares had been issued through a debt-to-equity conversion on Oct. 30, 2026.
  • The reported reduction ratio for minority shareholders was 0.01%; par value was KRW 500 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Union Korea Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261118900044), on November 18, 2026, and is solely responsible for the information contained therein.